 Connection
Cecilia Low Wang to Platelet Aggregation Inhibitors
This is a "connection" page, showing publications Cecilia Low Wang has written about Platelet Aggregation Inhibitors.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.965 |
|
|
|
-
Low Wang CC, Blomster JI, Heizer G, Berger JS, Baumgartner I, Fowkes FGR, Held P, Katona BG, Norgren L, Jones WS, Lopes RD, Olin JW, Rockhold FW, Mahaffey KW, Patel MR, Hiatt WR. Cardiovascular and Limb Outcomes in Patients With Diabetes and Peripheral?Artery Disease: The EUCLID Trial. J Am Coll Cardiol. 2018 12 25; 72(25):3274-3284.
Score: 0.494
-
Rogers RK, Hiatt WR, Patel MR, Shishehbor MH, White R, Khan ND, Bhalla NP, Jones WS, Low Wang CC. Ticagrelor in Peripheral Artery Disease Endovascular Revascularization (TI-PAD): Challenges in clinical trial execution. Vasc Med. 2018 12; 23(6):513-522.
Score: 0.470
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|